GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mydecine Innovations Group Inc (AQSE:MYIG) » Definitions » Balance Sheet Cash And Cash Equivalents

Mydecine Innovations Group (AQSE:MYIG) Balance Sheet Cash And Cash Equivalents


View and export this data going back to 2023. Start your Free Trial

What is Mydecine Innovations Group Balance Sheet Cash And Cash Equivalents?

Please go to this page to see Cash And Cash Equivalents for non-financial companies.


Mydecine Innovations Group (AQSE:MYIG) Business Description

Traded in Other Exchanges
Address
789 West Pender Street, Suite 810, Vancouver, BC, CAN, V6C 1H2
Mydecine Innovations Group Inc is a biopharma and life sciences company engaged in the research, drug development, and clinical trials of psilocybin products.